Reveal LINQ Insertable Cardiac Monitor vs eMurmur Heart AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Reveal LINQ Insertable Cardiac Monitor

by Medtronic

eMurmur Heart AI

by eMurmur

AI Verdict

These tools offer adjacent but distinct capabilities in cardiac diagnostics. Reveal LINQ provides long-term, continuous ECG monitoring via an implantable device to detect arrhythmias and reduce false alerts. In contrast, eMurmur Heart AI is a software platform that analyzes heart and lung sounds from digital stethoscopes for automated murmur detection and hemodynamic insights.

Choose Reveal LINQ Insertable Cardiac Monitor if…

Choose the Reveal LINQ Insertable Cardiac Monitor if you require long-term, continuous, and highly accurate subcutaneous ECG monitoring for patients with suspected infrequent arrhythmias like atrial fibrillation or unexplained syncope. This implantable device offers extended battery longevity and AI algorithms to significantly reduce false alerts, enhancing diagnostic yield over several years.

View Reveal LINQ Insertable Cardiac Monitor →

Choose eMurmur Heart AI if…

Choose eMurmur Heart AI if you need an immediate, non-invasive AI-powered solution for automated analysis of heart and lung sounds during patient encounters or telehealth consultations. This platform is ideal for screening, monitoring, and detecting murmurs, providing hemodynamic insights, and facilitating remote auscultation across various healthcare settings.

View eMurmur Heart AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Reveal LINQ Insertable Cardiac Monitor	eMurmur Heart AI
Pricing	Contact vendor	Contact for quote
Deployment	Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator.	Web-based, Mobile App, API integration
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Yes AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eMurmur Heart AI

eMurmur Heart AI (Tool B) offers superior usability due to its software-based, hardware-agnostic platform accessible via mobile apps and web portals, allowing flexible integration into diverse clinical workflows for active use. Reveal LINQ ICM (Tool A), while convenient for the patient post-implantation, involves an invasive procedure and is less versatile for varied clinical settings requiring active clinician interaction.

Clinical Value

Reveal LINQ Insertable Cardiac Monitor

Reveal LINQ ICM (Tool A) provides exceptional clinical value through its continuous, long-term ECG monitoring with AccuRhythmu2122 AI algorithms, which significantly reduce false alerts and enhance diagnostic yield for critical conditions like atrial fibrillation and syncope over an extended period. While eMurmur Heart AI (Tool B) offers valuable real-time auscultation analysis, Tool A addresses a more profound need for sustained diagnostic insight in chronic and intermittent cardiac rhythm disorders.

Pricing & Value

Tie

Both tools have opaque pricing models, requiring direct contact with the vendor, which makes a direct comparison of their cost-effectiveness impossible. While eMurmur Heart AI (Tool B) as a software solution might be perceived as having a lower entry cost, the long-term, continuous monitoring provided by Reveal LINQ ICM (Tool A) could offer significant value over its 4.5-year lifespan by preventing more severe events.

Enterprise Readiness

Reveal LINQ Insertable Cardiac Monitor

Reveal LINQ ICM (Tool A) benefits from being a Medtronic product, a global leader in medical devices, which implies a robust and proven infrastructure for large-scale enterprise deployment, integration, and long-term support within complex healthcare systems. While eMurmur Heart AI (Tool B) meets essential compliance requirements, CSD Labs does not possess the same scale, established track record, or extensive global support network as Medtronic.

Innovation

eMurmur Heart AI

eMurmur Heart AI (Tool B) demonstrates greater innovation by applying AI to automate and objectively analyze auscultation, a traditionally subjective clinical skill, and by offering hardware-neutral and remote capabilities. This approach represents a more disruptive and broadly applicable advancement in augmenting fundamental physical examinations. Reveal LINQ ICM's (Tool A) AI for false alert reduction is a significant refinement but less of a paradigm shift in a core diagnostic process.

Support & Docs

Reveal LINQ Insertable Cardiac Monitor

As a product from Medtronic, a global leader in medical technology, Reveal LINQ ICM (Tool A) is inherently backed by an extensive and well-established support network, comprehensive documentation, and robust training programs for both clinicians and patients. The provided facts do not offer comparable details regarding the breadth and depth of support and documentation available for eMurmur Heart AI (Tool B) from CSD Labs.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Reveal LINQ Insertable Cardiac Monitor	eMurmur Heart AI
Name	Reveal LINQ Insertable Cardiac Monitor	eMurmur Heart AI
Company	Medtronic	CSD Labs
Description	The Medtronic LINQ IIu2122 Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope.	eMurmur Heart AI by CSD Labs is an FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. It supports digital stethoscopes, mobile apps, and web portals for screening, monitoring, and remote consultation in various healthcare settings.
Primary Categories	Cardiology AI, Wearables & Remote Monitoring (RPM)	Cardiology AI, Telehealth & Virtual Care
Key Specialties	Cardiology, Pediatrics	Cardiology, Internal Medicine, Pulmonology
Core Functionality	Continuous, long-term subcutaneous ECG monitoring with AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause).	Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes), detection and classification of heart murmurs, and hemodynamic insights.

Videos

Demos, reviews, and walkthroughs featuring Reveal LINQ Insertable Cardiac Monitor and eMurmur Heart AI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and target patient populations for each tool?

The Medtronic Reveal LINQ ICM is designed for long-term, continuous subcutaneous ECG monitoring in cardiology and pediatrics, primarily for detecting arrhythmias like atrial fibrillation and syncope. eMurmur Heart AI by CSD Labs focuses on automated analysis of heart and lung sounds for screening, monitoring, and remote consultation across cardiology, internal medicine, and pulmonology, aiding in the detection and classification of heart murmurs and providing hemodynamic insights.

How do these tools integrate into a physician's existing clinical workflow for patient assessment and management?

The Reveal LINQ ICM is an implantable device that continuously monitors ECGs, with data transmitted remotely via a patient smartphone app or home communicator to a cloud-based platform for physician review of alerts and enhanced ECGs. eMurmur Heart AI integrates into the auscultation workflow, providing real-time AI analysis of heart and lung sounds via digital stethoscopes, mobile apps, and web portals during patient exams or telehealth consultations.

What specific features contribute to the accuracy and diagnostic value of each tool?

The Reveal LINQ ICM utilizes AccuRhythmu2122 AI algorithms to significantly reduce false alerts for atrial fibrillation and pause, thereby enhancing diagnostic yield for cardiac events. eMurmur Heart AI offers automated detection and classification of pathologic and innocent heart murmurs, along with hemodynamic insights like loudness ratios of S1, systole, S2, and diastole, to aid in the diagnosis of heart and lung conditions.

What capabilities do these tools offer for recording, storing, and reviewing patient data for monitoring or audit purposes?

The Reveal LINQ ICM provides continuous subcutaneous ECG monitoring, with data transmitted to the CareLinku2122 network for long-term review and clinical adjudication. eMurmur Heart AI allows for the recording, secure storage, and playback of auscultation data, enabling comparison of current and previous auscultation data for monitoring patient progress.

What is the expected learning curve for physicians and their staff to effectively utilize each tool in their practice?

For the Reveal LINQ ICM, the learning curve primarily involves understanding the remote monitoring platform (CareLinku2122 network) and interpreting AI-filtered ECG data for clinical adjudication. eMurmur Heart AI augments the existing skill of auscultation, requiring physicians to learn how to interpret the AI's analysis of heart and lung sounds and integrate it into their diagnostic process.

What are the key considerations for implementing and scaling each tool across multiple clinical sites or for a large patient population?

The Reveal LINQ ICM is an implantable device, so scaling involves individual patient procedures, with data accessible via a centralized cloud-based network (CareLinku2122). eMurmur Heart AI, being a cloud-based software with mobile and web access, is highly scalable for multi-site rollouts, requiring only compatible hardware (digital stethoscopes) and internet connectivity at each location.